Strategic partnership will focus on commercializing CELLSEARCH platform for COVID-19 related use cases, along with other COVID-19 related products BOLOGNA, Italy and HUNTINGDON VALLEY, Pa. and GAITHERSBURG, Md. — OpGen, Inc. (Nasdaq: OPGN), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, announced today that it has […]

CARLSBAD, Calif. — Thermo Fisher Scientific and First Genetics JCS, a manufacturer of diagnostic equipment and IVD kits intended to advance molecular genetic technologies into clinical practice, today announced a strategic partnership focused on commercializing next-generation sequencing (NGS)–based diagnostics in Russia. The agreement enables First Genetics to market its F-Genetics NGS System and IVD assays to Russian labs for […]

Modern Water is pleased to note that Integumen plc (“Integumen”), the Company’s reagent production agency partner, has entered into a collaboration agreement with Avacta plc (“Avacta”) for the evaluation of Avacta Affimers for the real-time identification of localised COVID-19 hotspots in wastewater, from which authorities can be alerted through Integumen’s real-time alert system to prevent […]

Maennedorf, Switzerland – Tecan is excited to announce an agreement with Thomas Scientific, a distributor of laboratory solutions and equipment, to support the sales of Tecan’s detection instruments and consumables portfolio in the US. This collaboration will allow Tecan to expand its presence for these product lines and reach a wider customer base across the […]

ANCOUVER, British Columbia — AbCellera Biologics today announced that it has filed a lawsuit in the United States District Court for the District of Delaware against Berkeley Lights, Inc. for patent infringement of U.S. Patent Nos. 10,107,812; 10,274,494; 10,466,241; 10,578,618; 10,697,962; 10,087,408; 10,421,936; and 10,704,018. By its complaint, AbCellera is seeking a declaration by the […]

BALTIMORE, MD  – PathSensors Inc., a Baltimore biotechnology company, announced today that Massachusetts Institute of Technology (MIT) has expanded the company’s exclusive license to include clinical applications for CANARY™ technology. This broader license allows PathSensors to move into the point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast and highly sensitive assays will […]

London and Oxford, UK: Today, LGC announced the acquisition of The Native Antigen Company (NAC), one of the world’s leading suppliers of high quality infectious disease antigens and antibodies. NAC is a developer, manufacturer and supplier of critical reagents to the in vitro diagnostic (IVD), pharmaceutical and academic sectors. It offers a comprehensive portfolio of native and recombinant […]

Lincoln, NE: The SARS-CoV-2 coronavirus and subsequent COVID-19 pandemic places the subject of viruses and virology in the research spotlight for good reason. Scientists are seeking to understand the virus, characterize infectivity, and understand its mechanism of action in their quest to develop therapeutics and vaccines. Key to this process are quantifiable assays that provide robust data for all aspects […]

FARMINGDALE, N.Y. – New York-based biotechnology firm EpiGentek has released a series of SARS-CoV-2 research assays in combatting the ongoing COVID-19 pandemic. The two kits focus on studies of SARS-CoV-2 targeted furin or proprotein convertase (PC) cleavage activity. These first-of-its-kind tools can be used to rapidly detect SARS-CoV-2 targeted PC and facilitated proteases using biological […]

Bionano’s new Bionano Prep™ SP Tissue and Tumor Kit enables routine analysis of cancer biopsies and animal tissue expanding its addressable market to include solid tumors and model genomes commonly studied in pharmaceutical research and development SAN DIEGO — Bionano Genomics, Inc. (Nasdaq: BNGO), today announced that it has launched the new Bionano PrepTM SP […]